Hantz Financial Services’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.51M | Buy |
227,241
+7,743
| +4% | +$120K | 0.06% | 249 |
|
|
2025
Q1 | $3.26M | Buy |
219,498
+327
| +0.1% | +$4.86K | 0.06% | 258 |
|
|
2024
Q4 | $2.9M | Sell |
219,171
-7,514
| -3% | -$99.5K | 0.05% | 280 |
|
|
2024
Q3 | $3.22M | Buy |
226,685
+6,967
| +3% | +$99.1K | 0.06% | 268 |
|
|
2024
Q2 | $2.84M | Sell |
219,718
-10,837
| -5% | -$140K | 0.05% | 275 |
|
|
2024
Q1 | $3.2M | Buy |
230,555
+3,298
| +1% | +$45.8K | 0.06% | 272 |
|
|
2023
Q4 | $3.24M | Sell |
227,257
-7,722
| -3% | -$110K | 0.07% | 274 |
|
|
2023
Q3 | $3.64M | Buy |
234,979
+3,383
| +1% | +$52.3K | 0.09% | 232 |
|
|
2023
Q2 | $3.64M | Sell |
231,596
-336
| -0.1% | -$5.28K | 0.09% | 232 |
|
|
2023
Q1 | $3.82M | Buy |
231,932
+45
| +0% | +$742 | 0.1% | 218 |
|
|
2022
Q4 | $3.62M | Sell |
231,887
-5,101
| -2% | -$79.6K | 0.11% | 217 |
|
|
2022
Q3 | $3.07M | Buy |
236,988
+3,864
| +2% | +$50.1K | 0.11% | 216 |
|
|
2022
Q2 | $3.27M | Buy |
233,124
+9,439
| +4% | +$133K | 0.11% | 209 |
|
|
2022
Q1 | $3.2M | Buy |
223,685
+42,526
| +23% | +$609K | 0.09% | 228 |
|
|
2021
Q4 | $2.47M | Buy |
181,159
+13,416
| +8% | +$183K | 0.07% | 245 |
|
|
2021
Q3 | $2.75M | Buy |
167,743
+30,136
| +22% | +$494K | 0.09% | 222 |
|
|
2021
Q2 | $2.32M | Buy |
137,607
+22,020
| +19% | +$371K | 0.08% | 231 |
|
|
2021
Q1 | $2.11M | Buy |
+115,587
| New | +$2.11M | 0.09% | 230 |
|